Cytomegalovirus pUL97 Kinase Inhibitors [MoA] - N0000193977

Pharmacologic Code	N0000193977
Pharmacologic Name	Cytomegalovirus pUL97 Kinase Inhibitors
Pharmacologic Uses	cytomegalovirus (CMV) pUL97 kinase inhibitor
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

The table contains 1 products whose active ingredient are classified under the same pharmacologic class Cytomegalovirus pUL97 Kinase Inhibitors [MoA].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	64764-800	Livtencity	Non-Proprietary Name: Maribavir	Tablet, Coated	Oral	Takeda Pharmaceuticals America, Inc.	ACTIVE